Sree Kant heads Business development at Life Biosciences and is focused on new scientific investments and strategic partnerships. Sree comes to Life with 18 years of varied healthcare and pharmaceutical industry experience. He previously was the head of early partnering strategy for Pfizer, working across different therapeutic areas/technologies and geographies with Academia, VCs/Banks, CROs, and other strategic partners. Sree was also a Principal at the Boston Consulting Group advising large pharma and biotech on R&D strategy as well as large M&A. He has an MBA from the Indian Institute of Management, and an MPH from the Harvard School of Public Health. Sree is an invited speaker at key industry events and conferences on subjects of R&D strategy, innovative partnering models, industry-academia collaborations, early-stage technologies and investments, etc.